Increased 18F-Fluorodeoxyglucose Uptake in Benign, Nonphysiologic Lesions Found on Whole-Body Positron Emission Tomography/Computed Tomography (PET/CT): Accumulated Data From Four Years of Experience With PET/CT

Seminars in Nuclear Medicine

Volumn 37, Issue 3, 2007, Pages 206-222

  Metser, Ur ^a,b   Even Sapir, Einat ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL SCINTISCANNING; BONE TISSUE; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; INFLAMMATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY ANALYSIS; SOFT TISSUE;

FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 34047174803     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2007.01.001     Document Type: Review

References (75)

1. Engel H., Steinert H., Buck A., et al. Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 37 (1996) 441-446
2. Hany T.F., Gharehpapagh E., Kamel E.M., et al. Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29 (2002) 1393-1398
3. 18F-FDG uptake on PET/CT: Characterization and incidence (2006) Presented at 2006 SNM Meeting, San Diego
4. Metser U., Golan O., Levine C.D., et al. Tumor lesion detection: When is integrated positron emission tomography/computed tomography more accurate than side-by-side interpretation of positron emission tomography and computed tomography?. J Comput Assist Tomogr 29 (2005) 554-559
5. Antoch G., Saoudi N., Kuehl H., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET. G. J Clin Oncol 22 (2004) 4357-4368
6. Pelosi E., Messa C., Sironi S., et al. Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study. Eur J Nucl Med Mol Imaging 31 (2004) 932-939
7. Reinartz P., Wieres F.J., Schneider W., et al. Side-by-side reading of PET and CT scans in oncology: Which patients might profit from integrated PET/CT?. Eur J Nucl Med Mol Imaging 31 (2004) 1456-1461
8. Roitt I.M., and Delves P.J. Lymphocyte activation. In: Roitt I.M. (Ed). Essential Immunology. (ed 10). (2001), Blackwell Scientific, Oxford, UK 164-176
9. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
10. Gamelli R.L., Liu H., He L.K., et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 59 (1996) 639-647
11. Fukuzumi M., Shinomya H., Shimizu Y., et al. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via Glut1. Infect Immun 64 (1996) 108-112
12. Paik J.Y., Lee K.H., Choe Y.S., et al. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med 45 (2004) 124-128
13. Babior B.M. The respiratory burst of phagocytes. J Clin Invest 73 (1984) 599-601
14. Yamada Y., Uchida Y., Tatsumi K., et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 39 (1998) 1160-1166
15. Walter M.A., Melzer R.A., Schindler C., et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32 (2005) 674-681
16. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes. J Clin Oncol 23 (2005) 7857-7863
17. Rice D.H. Diseases of the salivary glands-non-neoplastic. In: Bailey B.J., et al. (Ed). Head and Neck Surgery-Otolaryngology. (ed 2). (1933), JB Lippincott, Philadelphia, PA 19-37
18. Andrade R.S., Heron D.E., Degirmenci B., et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1315-1322
19. Asad S., Aquino S.L., Piyavisetpat N., et al. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 182 (2004) 983-989
20. Wheeler P.S., Stitik F.P., Hutchins G.M., et al. Diagnosis of lipoid pneumonia by computed tomography. JAMA 245 (1981) 65-66
21. Tahon F., Berthezene Y., Hominal S., et al. Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings. Eur Radiol 12 (2002) S171-S173
22. Brauner M.W., Grenier P., Mouelhi M.M., et al. Pulmonary histiocytosis X: Evaluation with high-resolution CT. Radiology 172 (1989) 255-258
23. Kamel E.M., McKee T.A., Calcagni M.L., et al. Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging 32 (2005) 641-646
24. Rossi S.E., Erasmus J.J., McAdams H.P., et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. RadioGraphics 20 (2000) 245-1259
25. Shin L., Katz D.S., and Yung E. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med 29 (2004) 654-656
26. Lee K.S., Kullnig P., Hartmanet T.E., et al. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR Am J Roentgenol 162 (1994) 543-554
27. Lynch D.A., Travis W.D., Muller N.L., et al. Idiopathic interstitial pneumonias: CT features. Radiology 236 (2005) 10-21
28. Messner H.H., Soo Hoo G.W., Khonsary S.A., et al. Idiopathic pulmonary fibrosis: Evaluation with positron emission tomography. Respiration 73 (2006) 197-202
29. Hassaballa H.A., Cohen E.S., Khan A.J., et al. Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest 128 (2005) 1448-1452
30. Tatlidil R., Jadvar H., Bading J.R., et al. Incidental colonic fluorodeoxyglucose uptake: Correlation with colonoscopic and histopathologic findings. Radiology 224 (2002) 783-787
31. Frick M.P., Maile C.W., Crass J.R., et al. Computed tomography of neutropenic colitis. AJR Am J Roentgenol 143 (1984) 763-765
32. Donnelly L.F., and Morris C.L. Acute graft-versus-host disease in children: Abdominal CT findings. Radiology 199 (1996) 265-268
33. Samuelson J., and Von Lichtenberg F. Infectious diseases. In: Cotran R.S., Kumar V., and Robbins S.L. (Eds). Pathologic basis of disease. (ed 5). (1994), Saunders, Philadelphia 305-377
34. Mergo P.J., and Ros P.R. MR imaging of inflammatory disease of the liver. Magn Reson Imaging Clin N Am 5 (1997) 367-376
35. Huang C.J., Pitt H.A., Lipsett P.A., et al. Pyogenic hepatic abscess. Ann Surg 223 (1996) 600-609
36. Von Lichtenberg F. Infectious diseases. In: Cotran R.S., Kumar V., and Robbins S.L. (Eds). Pathologic basis of disease. (ed 3). (1984), Saunders, Philadelphia 385-386
37. Balthazar E.J. Acute pancreatitis: Assessment of severity with clinical and CT evaluation. Radiology 223 (2002) 603-613
38. Metser U., Miller E., Kessler A., et al. Solid splenic masses: evaluation with 18F-FDG PET/CT. J Nucl Med 46 (2005) 52-59
39. Rao P.M., Wittenberg J., and Lawrason J.N. Primary epiploic appendagitis: Evolutionary changes in CT appearance. Radiology 204 (1997) 713-717
40. Horton K.M., Lawler L.P., and Fishman E.K. CT findings in sclerosing mesenteritis (panniculitis): Spectrum of disease. Radiographics 23 (2003) 1561-1567
41. Zissin R., Metser U., Hain D., et al. Mesenteric panniculitis in oncologic patients: PET-CT findings. U. Br J Radiol 79 (2006) 37-43
42. 18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30 (2003) 267-273
43. Weber W.A. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46 (2005) 983-995
44. Ak I., and Can C. F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol 46 (2005) 895-899
45. Swingle C.A., Baumgarten D.A., and Schuster D.M. Xanthogranulomatous pyelonephritis characterized on PET/CT. Clin Nucl Med 30 (2005) 728-729
46. Majd M., Nussbaum Blask A.R., Markle B.M., et al. Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model. Radiology 218 (2001) 101-108
47. Hayes W.S., Hartman D.S., and ISesterbenn I.A. From the Archives of the AFIP: Xanthogranulomatous pyelonephritis. Radiographics 11 (1991) 485-498
48. Walsh J.W. Computed tomography of gynecologic neoplasms. Radiol Clin North Am 30 (1992) 817-818
49. de Winter F., van de Wiele C., Vogelaers D., et al. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83 (2001) 651-660
50. Mahfouz T., Miceli M.H., Saghafifar F., et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes. J Clin Oncol 23 (2005) 7857-7863
51. Schweitzer M.E., and Morrison W.B. MR imaging of the diabetic foot. Radiol Clin North Am 42 (2004) 61-71
52. Keidar Z., Militianu D., Melamed E., et al. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 46 (2005) 444-449
53. Harkess J.W. Arthroplasty of hip. In: Canale S.T. (Ed). Campbell's Operative Orthopaedics. (ed 9). (1998), Mosby, St. Louis 296-456
54. Stumpe K.D., Notzli H.P., Zanetti M., et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231 (2004) 333-341
55. Delank K.S., Schmidt M., Michael J.W., et al. The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: Results from a prospective, blinded study. BMC Musculoskelet Disord 7 (2006) 20
56. Liu S.H., Chang J.T., Ng S.H., et al. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. Br J Radiol 77 (2004) 257-260
57. Wandler E., Kramer E.L., Sherman O., et al. Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. AJR Am J Roentgenol 185 (2005) 797-803
58. Wendling D., Blagosklonov O., Streit G., et al. FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment. Ann Rheum Dis 64 (2005) 1663-1665
59. Beckers C., Jeukens X., Ribbens C., et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33 (2006) 275-280
60. Beckers C., Ribbens C., Andre B., et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45 (2004) 956-964
61. Campanella N., Moraca A., Pergolini M., et al. Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: Can they help in early detection?. Med Oncol 16 (1999) 129
62. Herder G.J., Welling A., De Winter G.V., et al. Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma. Clin Nucl Med 28 (2003) 58-59
63. Blockmans D., Stroobants S., Maes A., et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am J Med 108 (2000) 246-249
64. Kobayashi Y., Ishii K., Oda K., et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 46 (2005) 917-922
65. Shim S.S., Lee K.S., Kim B.T., et al. Non-small cell lung cancer: Prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236 (2005) 1011-1019
66. Reddy M.P., and Graham M.M. FDG positron emission tomographic imaging of thoracic Castleman's disease. Clin Nucl Med 28 (2003) 325-326
67. Lim R., Wittram C., Ferry J.A., et al. FDG PET of Rosai-Dorfman disease of the thymus. AJR Am J Roentgenol 182 (2004) 514
68. De Souza B., Brunetti A., Fulham M.J., et al. Pituitary microadenomas: A PET study. Radiology 177 (1990) 39-44
69. Metser U., Miller E., Lerman H., et al. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47 (2006) 32-37
70. Yasuda S., Fujii H., Nakahara T., et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 42 (2001) 989-992
71. Aoki J., Watanabe H., Shinozaki T., et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 219 (2001) 774-777
72. Watanabe H., Shinozaki T., Yanagawa T., et al. Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET. J Nucl Med 41 (2000) 1695-1701
73. Urban B.A., Fishman E.K., Goldman S.M., et al. CT evaluation of amyloidosis: Spectrum of disease. Radiographics 13 (1993) 1295-1308
74. Fan C.M., Fischman A.J., Kwek B.H., et al. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol 184 (2005) 339-342
75. Tsuchiya T., Osanai T., Ishikawa A., et al. Hibernomas show intense accumulation of FDG positron emission tomography. J Comput Assist Tomogr 30 (2006) 333-336